Teva Pharmaceutical Industries Ltd
TEVA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818686
In the last 90 days, Teva Pharmaceutical Industries Ltd insiders filed 0 open-market purchases and 8 sales; 675 institutions reported holding it in 13F filings for Q2 2026, worth $24.7B in total; 3 superinvestors hold it, including Greenlight Capital and Duquesne Family Office.
Q3 2021 vs. Q2 2021
How the institutions holding Teva Pharmaceutical Industries Ltd changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 441 | 7 | 430 | −4 |
| Shares | 560.5M | 575.6K | 527.5M | −32.5M (−5.8%) |
| Value | $5.55B | $5.72M | $5.14B | −$407.0M (−7.3%) |
7 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (36)
Institutions that held Teva Pharmaceutical Industries Ltd at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (40)
Institutions that held Teva Pharmaceutical Industries Ltd at the end of Q2 2021 and filed for Q3 2021 without it.
Not filed for Q3 2021 yet (7)
Institutions that held Teva Pharmaceutical Industries Ltd at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 336,450 | $3.35M |
| Usca Ria LLC | 128,300 | $1.27M |
| Cowen Prime Services LLC | 81,294 | $805.0K |
| Vontobel Swiss Wealth Advisors AG | 27,895 | $276.0K |
| CWM, LLC | 1,105 | $11.0K |
| Horan Securities, Inc. | 510 | $5.00K |
| Hoover Financial Advisors, Inc. | 75 | $1.00K |